Liothyronine for hypothyroidism: a candidate for disinvestment or in need of further research? A value of information analysis
Objective Medicines with limited evidence of effectiveness are prime candidates for disinvestment. However, investment in further research may be preferable to deimplementation, given that the absence of evidence is not evidence of absence, and research can inform formulary decisions. A case in poin...
Saved in:
| Main Authors: | Dyfrig A Hughes, Pippa Anderson, Adrian Heald, Konstantinos Skiadas |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-12-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/11/12/e051702.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A feasibility double-blind trial of levothyroxine vs. levothyroxine-liothyronine in postsurgical hypothyroidism
by: Giao Q. Phan, et al.
Published: (2025-03-01) -
Treatment of hypothyroidism with levothyroxine plus slow-release liothyronine: a study protocol for a randomized controlled double-blinded clinical trial
by: F. Azizi, et al.
Published: (2025-07-01) -
State ownership and firm performance: A performance evaluation of disinvested public sector enterprises
by: I. Chhabra, et al.
Published: (2021-12-01) -
Quality by design driven RP-HPLC method optimization for analysis of levothyroxine and liothyronine in bulk and tablet dosage form
by: Ramdas Darade, et al.
Published: (2025-04-01) -
Profitability and Market Value of Orphan Drug Companies: A Retrospective, Propensity-Matched Case-Control Study.
by: Dyfrig A Hughes, et al.
Published: (2016-01-01)